Gå direkt till innehåll
Setterwalls Life Sciences Report May 2024

Nyhet -

Setterwalls Life Sciences Report May 2024

Setterwalls har idag publicerat Life Sciences Report May 2024 som samlar nyheter och artiklar författade av våra specialister inom juridik avseende life sciences-området. Vi hoppas ni finner innehållet intressant och ger här en översikt över innehållet samt länkning till hela rapporten. God läsning och välkommen att kontakta oss!

  • New regulation introduces stricter accessibility requirements – do your products and services meet the new requirements?
  • Overview of recent developments regarding the distinction between marketing and non-commercial information in relation to medicinal products.
  • The new Product Liability Directive and AI Liability Directive – implications for medical devices with AI functionalities.
  • Key takeaways for the environmental risk assessment (ERA) in the proposal for new EU pharmaceutical legislation.
  • EMA’s new recommendations to strengthen supply chains of critical medicines – a short recap of what and why
    Recent developments and an update on Geographical Indications (GIs).
  • Switch and substitution of biological medicinal products in pharmacies.
  • The Swedish Supreme Administrative Court seeks guidance from the CJEU on the interpretation of the provisions of EU law on the labelling of food for special medical purposes.
  • Labelling sausages “riktig korv” (eng. real sausage) was misleading.

Du hittar rapporten och alla individuella länkar här.

Relaterade länkar

Ämnen

Kategorier

Kontakter

  • Setterwalls-Forskning-detalj.jpg
    Setterwalls-Forskning-detalj.jpg
    Licens:
    All rights reserved
    Filformat:
    .jpg
    Storlek:
    7680 x 4320, 17,4 MB